Monovisc

Viscosupplementation, a minimally invasive treatment for osteoarthritis, has seen significant market growth. It was valued at $4.4 billion in 2021 and...

Knee injections are a standard treatment for osteoarthritis, but they have potential side effects. According to various studies on the safety and effi...

Knee osteoarthritis is a prevalent condition that has led to significant healthcare interventions. In 2021 and 2022, over 53,500 knee replacements wer...

Osteoarthritis affects a staggering 595 million people globally, representing 7.6% of the population in 2020, with a projected increase in prevalence ...

Osteoarthritis (OA) is a degenerative joint disease that has grown significantly in prevalence. In 2019, approximately 528 million people were affecte...

Knee osteoarthritis (OA) is a prevalent condition that affects millions globally, presenting a significant challenge in pain management and mobility. ...

Viscosupplementation, a treatment for knee osteoarthritis, involves injecting hyaluronic acid into the joint to lubricate and cushion it. While some s...

Viscosupplementation has emerged as a leading treatment for osteoarthritis, with numerous studies highlighting its effectiveness. Studies have found t...

Accurate prescribing information is crucial for healthcare professionals to ensure patient safety and treatment efficacy. Monovisc, a high-molecular-w...

A relevant study published in Orthopedic Reviews found that viscosupplementation with sodium hyaluronate significantly reduces knee pain and improves ...